Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiano Buti

Showing results (71-80 of 336) with videos related to

Pageof 34
Sort By:
Tumori|December 7, 2022
BONSAI-2 study: Nivolumab as therapeutic option after cabozantinib failure in metastatic collecting duct carcinoma patientsSebastiano Buti, Francesca Trentini, Pierangela Sepe, et al.
Immunotherapy|November 21, 2022
Takotsubo syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab plus axitinibGiulia Airò, Michele Maffezzoli, Alessandro Lazzarin, et al.
Oncology|December 3, 2008
Chronically administered immunotherapy with low-dose IL-2 and IFN-alpha in metastatic renal cell carcinoma: a feasible option for patients with a good prognostic profileAugusto Vaglio, Federico Alberici, Umberto Maggiore, et al.
Critical Reviews in Oncology/Hematology|July 21, 2019
Effectiveness and safety of "real" concurrent stereotactic radiotherapy and immunotherapy in metastatic solid tumors: a systematic reviewSalvatore Trapani, Moana Manicone, Angelica Sikokis, et al.
Human Vaccines & Immunotherapeutics|May 17, 2024
Banana-shaped survival curves of metastatic renal cell carcinoma treated with first-line immune-combinations, not just a matter of "palateau"Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Impressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinomaSebastiano Buti, Maddalena Donini, Pietro Sergio, et al.
World Journal of Radiology|September 27, 2021
Differential diagnosis of COVID-19 at the chest computed tomography scan: A review with special focus on cancer patientsFabiana Perrone, Maurizio Balbi, Chiara Casartelli, et al.
Clinical Genitourinary Cancer|February 23, 2016
Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic ReviewAlessandro Leonetti, Melissa Bersanelli, Bruno Castagneto, et al.
Gynecologic and Obstetric Investigation|June 17, 2016
Primary Retroperitoneal Cystoadenocarcinoma: A Systematic ReviewBenedetta Pellegrino, Angelica Sikokis, Melissa Bersanelli, et al.
Current Oncology Reports|October 19, 2023
Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian ExpertsDaniele Santini, Giuseppe Luigi Banna, Sebastiano Buti, et al.
Pageof 34

Showing results (71-80 of 336) with videos related to

Sort By:
Pageof 34
Tumori|December 7, 2022
BONSAI-2 study: Nivolumab as therapeutic option after cabozantinib failure in metastatic collecting duct carcinoma patientsSebastiano Buti, Francesca Trentini, Pierangela Sepe, et al.
Immunotherapy|November 21, 2022
Takotsubo syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab plus axitinibGiulia Airò, Michele Maffezzoli, Alessandro Lazzarin, et al.
Oncology|December 3, 2008
Chronically administered immunotherapy with low-dose IL-2 and IFN-alpha in metastatic renal cell carcinoma: a feasible option for patients with a good prognostic profileAugusto Vaglio, Federico Alberici, Umberto Maggiore, et al.
Critical Reviews in Oncology/Hematology|July 21, 2019
Effectiveness and safety of "real" concurrent stereotactic radiotherapy and immunotherapy in metastatic solid tumors: a systematic reviewSalvatore Trapani, Moana Manicone, Angelica Sikokis, et al.
Human Vaccines & Immunotherapeutics|May 17, 2024
Banana-shaped survival curves of metastatic renal cell carcinoma treated with first-line immune-combinations, not just a matter of "palateau"Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Impressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinomaSebastiano Buti, Maddalena Donini, Pietro Sergio, et al.
World Journal of Radiology|September 27, 2021
Differential diagnosis of COVID-19 at the chest computed tomography scan: A review with special focus on cancer patientsFabiana Perrone, Maurizio Balbi, Chiara Casartelli, et al.
Clinical Genitourinary Cancer|February 23, 2016
Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic ReviewAlessandro Leonetti, Melissa Bersanelli, Bruno Castagneto, et al.
Gynecologic and Obstetric Investigation|June 17, 2016
Primary Retroperitoneal Cystoadenocarcinoma: A Systematic ReviewBenedetta Pellegrino, Angelica Sikokis, Melissa Bersanelli, et al.
Current Oncology Reports|October 19, 2023
Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian ExpertsDaniele Santini, Giuseppe Luigi Banna, Sebastiano Buti, et al.
Pageof 34